TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer

F. A. Castro, Asta Försti, S. Buch, H. Kalthoff, C. Krauss, M. Bauer, J. Egberts, B. Schniewind, D. C. Broering, S. Schreiber, M. Schmitt, J. Hampe, Kari Hemminki, C. Schafmayer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology